CD4 and myeloid sarcoma: Although the specific effects of CX3CR1 in CD4+ CTLs are unclear, a previous study in MS has demonstrated that CX3CR1 drives the migration of CD4+ CTLs into the CNS and enhances their cytotoxic activity.44